Skip to main content
Transparency
Twitter
YouTube
Linkedin
cat
esp
eng
ABOUT US
RESEARCH
COVID-19
INNOVATION AND TRANSFER
LEARNING
LIVING LAB HEALTH
NEWS
COLLABORATE
Cerca
who are you?
Who are you?
I'm an
Investigator
I'm
Community
I'm an
Educator
or Student
I'm a
Collaborator
I'm a
Journalist
IrsiCaixa’s scientific activity search engine
Search by
Filter by strategic line
All lines
Immunopathogenesis
Microbiome
Other diseases
Prevention, eradication and functional cure
New treatments and resistance to antiretrovirals
Filter by research group
All the groups
Retrovirology and Clinical Studies (GREC)
Cell Virology and Immunology (VIC)
Microbial Genomics
Virus-Host Interactions (ViHIT)
Host Genetics and Cellular Immunity
HIV and HCV Genetic and Phenotypic Variability
Tissue Virology (VITI)
Viral Immune Evasion and Vaccines (VIRIEVAC)
Neoantigens and Therapeutic Vaccines for Cancer (NeoVaCan)
Pathogen immunity, signaling and therapeutic applications (PISTA)
Translational Research in Immunology and Aging (TRIA)
From Date
Date
To Date
Date
Search
Filter by category
Strategic lines
Research groups
Researchers
Projects
Publications
Clinical research
Events
Publication
The Cortical Actin Determines Different Susceptibility of Naïve and Memory CD4+ T Cells to HIV-1 Cell-to-Cell Transmission and Infection
Publication
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control
Publication
Insights from host genomics into HIV infection and disease: Identification of host targets for drug development
Publication
Quasispecies Dynamics of RNA Viruses [In: Viruses: Essential Agents of Life]
Publication
HIV-1 Tropism Testing in Subjects Achieving Undetectable HIV-1 RNA: Diagnostic Accuracy, Viral Evolution and Compartmentalization
Publication
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls
Publication
Changes in codon-pair bias of human immunodeficiency virus type 1 have profound effects on virus replication in cell culture
Publication
Identification of Hck Inhibitors As Hits for the Development of Antileukemia and Anti-HIV Agents
Publication
Significant changes in integrase-associated HIV-1 replication capacity between early and late isolates
Publication
Impact of Antiretroviral Drugs in Pregnant Women and Their Children in Africa: HIV Resistance and Treatment Outcomes
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »
IrsiCaixa: -- No us perdeu les respostes de la Dra @BeaMothe, d'IrsiCaixa, als dubtes dels oients d'@elmonarac1 sobre la vacuna! -- Els vacunats poden transmetre el virus? Qui ha passat la COVID-19 s'ha de vacunar? Totes les vacunes van ig
IrsiCaixa: RT @FLSida: --La vacunación frente a la #COVID19 está recomendada para todas las personas que viven con #VIH. Este colectivo se encuentra en…
IrsiCaixa: RT @elmonarac1: -- EN DIRECTE - Resolem els dubtes sobre la vacuna contra el coronavirus amb @BeaMothe, metgessa i investigadora de la Funda…
IrsiCaixa: -- "Desde que se recibe la 2a dosis, se necesitaría una semana aprox. para que el sistema inmune desarrolle una respuesta protectora contra el #SARSCoV2" --️ Jorge Carrillo, investigador principal en #IrsiCaixa, sobre la vacuna co
IrsiCaixa: RT @linformatiu_tve: Què passa si ens contagiem enmig del procés de vacunació? Quan assolirem la immunitat? @marta_sugranes entrevista Jo…
IrsiCaixa: RT @hivandco_2020: Enhorabuena compañer@s del @SaludISCIII @ibis_sevilla @IrsiCaixa al reconocimiento de la revista Science por la publicac…
IrsiCaixa: RT @FAQSTV3: "La vacuna anirà bé però d'aquí a que generi aquesta immunitat poblacional i puguem mantenir la pandèmia i no hi hagi rebrots…
IrsiCaixa: RT @FAQSTV3: "El 2012, amb l'aparició del MERS, s'hauria d'haver dedicat molts diners a prevenir que aparegués una nova variant pitjor. Cal…
IrsiCaixa: RT @FAQSTV3: -- El president del Parlament, Roger Torrent; els doctors Bonaventura Clotet i Oriol Mitjà, i el sociòleg portuguès Boaventura…
IrsiCaixa: -- Ha arribat el dia! El Dr Bonaventura Clotet, director d'IrsiCaixa, ha rebut avui la primera dosi de la vacuna. ---- #JoEmVacuno contra la COVID-19, per tothom qui no pot fer-ho i per poder tornar a abraçar-nos ben aviat! ---- Seguim
Subscribe to our newsletter
I accept the sending of communications about IrsiCaixa activities, promotions and scientific and educational innovations
*
es
ca
en
Back to Top